United Kingdom · Question · Written question
UIN 128177
NHS: Drugs
Introduced
17 April 2026
Last action
28 April 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 April 2026
Summary
To ask the Secretary of State for Health and Social Care, whether non-animal alternatives must be validated if they are being used to provide data on the safety and efficacy of potential new pharmaceuticals within submissions to the Medicines and Healthca
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 April 2026
Written question
To ask the Secretary of State for Health and Social Care, whether non-animal alternatives must be validated if they are being used to provide data on the safety and efficacy of potential new pharmaceuticals within submissions to the Medicines and Healthca
Source: Commons
28 April 2026
Answer
The term ‘validation’ is broad and subject to a variety of definitions. Regarding the use of animal models for submission to the Medicines and Healthcare products Regulatory Agency (MHRA), non-animal alternatives must be demonstrated to be fit for the pur...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-04-17/128177
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1900875
- uk · wq-1900875 · source updated 28 April 2026